Spartan Bioscience Partners with the Global Alzheimer’s Platform Foundation to Accelerate Alzheimer’s Research

Ottawa, Canada – Spartan Bioscience announced a partnership with the Global Alzheimer’s Platform Foundation® (GAP) to help recruit possible study participants and accelerate Alzheimer’s clinical trials. Through the partnership, Spartan will donate $5 from each sale of its rapid Apolipoprotein E (APOE) genetic pre-screening test to the GAP Transportation Program, which is powered by Lyft. […]

Read More…

Global Alzheimer’s Platform Foundation Honors More Than 100 Clinical Trial Participants During National Citizen Scientist Week.

Washington, DC  – June 17-21, 2019 is the first ever National Citizen Scientist Week, a time to honor people who volunteer for Alzheimer’s research and inspire hope for new therapies for the disease. To celebrate the contributions of the remarkable volunteers who are participating in Alzheimer’s clinical trials, the Global Alzheimer’s Platform Foundation (GAP) is […]

Read More…

Global Alzheimer’s Platform Foundation Commends National Institute on Aging for Advancing Its 2025 Goal by Funding a Diversified Portfolio of Studies

Washington, DC  – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, today issued the following statement: ““The nearly six million Americans with Alzheimer’s and their families deserve for no scientific stone to go unturned in the search for a cure. The Global Alzheimer’s Platform Foundation commends the National Institute on Aging for […]

Read More…

Global Alzheimer’s Platform Foundation Commends Commissioner Seema Verma and CMS for New Medicare Advantage Benefits and Payment Policies That Will Improve the Care Of Beneficiaries At Risk For Alzheimer’s and Related Dementias

Washington, DC  – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, today issued the following statement: “The Global Alzheimer’s Platform Foundation thanks Commissioner Seema Verma and the Centers for Medicare and Medicaid Services (CMS) for its thoughtful and impactful leadership in implementing policies that will improve Medicare Advantage beneficiaries’ ability to maintain […]

Read More…

GAP Foundation Unveils Roadmap for Increasing Participation in Alzheimer’s Research

GAP President Calls Memory Fitness Programs Through Medicare Advantage “a Game-Changer” Nashville – Global Alzheimer’s Platform Foundation (GAP) President John Dwyer today announced a roadmap for increasing participation in Alzheimer’s clinical trials by supporting and collaborating with memory fitness supplemental benefit programs offered through select Medicare Advantage plans across the United States. Dwyer made the announcement […]

Read More…

Leading Alzheimer’s Researchers Coming to Nashville for GAP-Net Site Optimization Conference

Researchers, recruiters, and CEOs from more than 70 Alzheimer’s clinical trial sites to share strategies on finding a cure for the deadly disease From February 27 – March 1, the Global Alzheimer’s Platform Foundation (GAP), an organization dedicated to speeding and improving Alzheimer’s clinical trials in pursuit of a cure, will convene more than 150 representatives […]

Read More…

Barrow Receives $100,000 Grant for Alzheimer’s Program

Global Alzheimer’s Platform Foundation recognizes strong, expanding research WASHINGTON, DC (February 19, 2019) – The Global Alzheimer’s Platform Foundation (GAP) announced a $100,000 grant to the Barrow Neurological Foundation to optimize and support the Alzheimer’s clinical trials program at Barrow Neurological Institute at Dignity Health St. Joseph’s Hospital and Medical Center. The grant will go toward […]

Read More…

$90,000 GAP Grant to Toronto Memory Program Funds Alzheimer’s Education & Outreach

Grant Funds January 28 Community Event at Ontario Science Centre and Expanded Clinical Trial Education Programs TORONTO -The Global Alzheimer’s Platform Foundation and Toronto Memory Program have initiated a multi-faceted project to educate the Ontario community about Alzheimer’s disease, brain health and the role of Alzheimer’s clinical trials. Toronto Memory Program is a member of the GAP-Net network of 70 […]

Read More…

Chicago Event to Encourage Participation in Alzheimer’s Clinical Research

Event is on November 8, Chicago Alzheimer’s Awareness DayWASHINGTON, D.C. – On November 8th – Chicago Alzheimer’s Awareness Day – Great Lakes Clinical Trials and the Global Alzheimer’s Platform Foundation are hosting a major community event for people in the community who are interested in learning more about memory concerns and Alzheimer’s disease. Research volunteers, including care partners, are being […]

Read More…

Statement from Global Alzheimer’s Platform (GAP) Foundation on the National Strategy for Recruitment and Participation in Alzheimer’s Disease Clinical Research

WASHINGTON, D.C. – “I would like to thank the National Institute on Aging for its thoughtful work on the national strategy. More effective recruitment means faster trials and getting approved therapies to market years sooner. The Global Alzheimer’s Platform Foundation is pleased to join in this effort by building a better research infrastructure through GAP-NET, its […]

Read More…